Prof John Gribben and Prof Andre Goy at ASH 2014: Treating mantle cell lymphoma (Part 3) - European Medical Journal

Prof John Gribben and Prof Andre Goy at ASH 2014: Treating mantle cell lymphoma (Part 3)

Hematology

Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Andre Goy (John Theurer Cancer Center, Hackensack, NJ) at the 2014 American Society of Hematology (ASH) Annual Meeting about maintenance therapy with rituximab for the management of patients with mantle cell lymphoma.

This programme has been supported by sponsorship from Celgene.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>